Leading investors warn that the sharemarket's ascent to the 7000 points level helped by the lowest interest rates in history should be met with caution and may not be supported by earnings in an economy growing below-trend.
A formalised phase one trade deal between the US and China pushed the Australian market to a record 7041.8 on Thursday and biotech champion CSL to an all-time high of $300.89.
Loading...
Sarah Turner is the editor of the AFR Weekend Perspective section based in our Sydney newsroom. Email Sarah at s.turner@afr.com
Vesna Poljak is the Companies editor. She was previously the Markets editor with a special interest in the investment industry, hedge funds and accounting. She is based in the Sydney newsroom. Connect with Vesna on Twitter. Email Vesna at vpoljak@afr.com
